BFO

Boston Family Office’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,763	Closed	-$332K	–	285
2025 Q1	$332K	Hold	9,763	–	–	0.02%	231
2024 Q4	$384K	Hold	9,763	–	–	0.03%	218
2024 Q3	$459K	Buy	9,763 +213	+2%	+$10K	0.03%	208
2024 Q2	$516K	Hold	9,550	–	–	0.04%	193
2024 Q1	$651K	Hold	9,550	–	–	0.05%	171
2023 Q4	$598K	Hold	9,550	–	–	0.05%	175
2023 Q3	$433K	Hold	9,550	–	–	0.04%	197
2023 Q2	$536K	Hold	9,550	–	–	0.04%	183
2023 Q1	$432K	Hold	9,550	–	–	0.03%	203
2022 Q4	$388K	Hold	9,550	–	–	0.03%	213
2022 Q3	$624K	Hold	9,550	–	–	0.06%	175
2022 Q2	$580K	Hold	9,550	–	–	0.05%	186
2022 Q1	$599K	Hold	9,550	–	–	0.04%	190
2021 Q4	$724K	Hold	9,550	–	–	0.05%	181
2021 Q3	$1.07M	Hold	9,550	–	–	0.08%	155
2021 Q2	$1.55M	Hold	9,550	–	–	0.11%	137
2021 Q1	$1.16M	Sell	9,550 -750	-7%	-$91.3K	0.09%	149
2020 Q4	$1.58M	Hold	10,300	–	–	0.12%	130
2020 Q3	$861K	Hold	10,300	–	–	0.08%	157
2020 Q2	$757K	Hold	10,300	–	–	0.07%	157
2020 Q1	$437K	Hold	10,300	–	–	0.05%	178
2019 Q4	$627K	Sell	10,300 -100	-1%	-$6.09K	0.06%	175
2019 Q3	$426K	Hold	10,400	–	–	0.04%	202
2019 Q2	$490K	Hold	10,400	–	–	0.05%	196
2019 Q1	$371K	Hold	10,400	–	–	0.04%	217
2018 Q4	$297K	Sell	10,400 -100	-1%	-$2.86K	0.04%	221
2018 Q3	$466K	Buy	10,500 +100	+1%	+$4.44K	0.05%	202
2018 Q2	$611K	Buy	10,400 +400	+4%	+$23.5K	0.07%	178
2018 Q1	$457K	Buy	+10,000	New	+$457K	0.05%	203